Designing a therapeutic and prophylactic candidate vaccine against human papillomavirus through vaccinomics approaches

CONCLUSION: Ultimately, this study led to suggest the designed construct as a potential vaccine candidate with both prophylactic and therapeutic applications against HPV by promoting Th1, Th2, CTL, and B cell immune responses, which should be further confirmed in experimental studies.PMID:34547435 | DOI:10.1016/j.meegid.2021.105084

Source: Infection, Genetics and Evolution - September 21, 2021 Category: Genetics & Stem Cells Authors: Ashkan Bagheri Navid Nezafat Mahboobeh Eslami Younes Ghasemi Manica Negahdaripour Source Type: research